Literature DB >> 30928514

Massive integrative gene set analysis enables functional characterization of breast cancer subtypes.

Juan C Rodriguez1, Gabriela A Merino2, Andrea S Llera3, Elmer A Fernández4.   

Abstract

The availability of large-scale repositories and integrated cancer genome efforts have created unprecedented opportunities to study and describe cancer biology. In this sense, the aim of translational researchers is the integration of multiple omics data to achieve a better identification of homogeneous subgroups of patients in order to develop adequate diagnostic and treatment strategies from the personalized medicine perspective. So far, existing integrative methods have grouped together omics data information, leaving out individual omics data phenotypic interpretation. Here, we present the Massive and Integrative Gene Set Analysis (MIGSA) R package. This tool can analyze several high throughput experiments in a comprehensive way through a functional analysis strategy, relating a phenotype to its biological function counterpart defined by means of gene sets. By simultaneously querying different multiple omics data from the same or different groups of patients, common and specific functional patterns for each studied phenotype can be obtained. The usefulness of MIGSA was demonstrated by applying the package to functionally characterize the intrinsic breast cancer PAM50 subtypes. For each subtype, specific functional transcriptomic profiles and gene sets enriched by transcriptomic and proteomic data were identified. To achieve this, transcriptomic and proteomic data from 28 datasets were analyzed using MIGSA. As a result, enriched gene sets and important genes were consistently found as related to a specific subtype across experiments or data types and thus can be used as molecular signature biomarkers.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Big omics data; Biological insight; Breast cancer; Functional analysis; Knowledge discovery; Multiple omics

Year:  2019        PMID: 30928514     DOI: 10.1016/j.jbi.2019.103157

Source DB:  PubMed          Journal:  J Biomed Inform        ISSN: 1532-0464            Impact factor:   6.317


  4 in total

Review 1.  Computational Oncology in the Multi-Omics Era: State of the Art.

Authors:  Guillermo de Anda-Jáuregui; Enrique Hernández-Lemus
Journal:  Front Oncol       Date:  2020-04-07       Impact factor: 6.244

2.  Pan-Cancer Molecular Patterns and Biological Implications Associated with a Tumor-Specific Molecular Signature.

Authors:  Darío Rocha; Iris A García; Aldana González Montoro; Andrea Llera; Laura Prato; María R Girotti; Gastón Soria; Elmer A Fernández
Journal:  Cells       Date:  2020-12-31       Impact factor: 6.600

3.  Topology-enhanced molecular graph representation for anti-breast cancer drug selection.

Authors:  Yue Gao; Songling Chen; Junyi Tong; Xiangling Fu
Journal:  BMC Bioinformatics       Date:  2022-09-19       Impact factor: 3.307

Review 4.  Multi-Omics Model Applied to Cancer Genetics.

Authors:  Francesco Pettini; Anna Visibelli; Vittoria Cicaloni; Daniele Iovinelli; Ottavia Spiga
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.